Gemphire Therapeutics Inc buy melinda
Start price
23.10.17
/
50%
?245.75
Target price
26.12.17
€275.00
Performance (%)
-16.79%
End price
26.12.17
€204.50
Summary
This prediction ended on 26.12.17 with a price of €204.50. The prediction for Gemphire Therapeutics Inc disappointed with a performance of -16.79%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gemphire Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 3.201% | 53.313% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 20.240% | 93.480% |
| iShares Nikkei 225® | -1.082% | -7.987% | 27.550% | 52.317% |
| iShares S&P 500 | -0.055% | 0.880% | 14.887% | 66.737% |
Comments by melinda for this prediction
In the thread Gemphire Therapeutics Inc diskutieren
Positive Ergebnisse aus einer präklinischen Studie in Gemcabene NASH an der Leber Meeting® 2017 vorbestellt präsentiert
(Vom Mitglied beendet)
Stopped prediction by melinda for Gemphire Therapeutics Inc
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?27.75
14.11.18
14.11.18
€31.57
04.12.18
04.12.18
12.14%
04.12.18
04.12.18
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?221.67
23.10.17
23.10.17
€248.05
26.12.17
26.12.17
-16.79%
26.12.17
26.12.17
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?293.83
29.06.17
29.06.17
€383.35
18.07.17
18.07.17
24.92%
18.07.17
18.07.17
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?325.75
29.06.17
29.06.17
€425.00
18.07.17
18.07.17
24.92%
18.07.17
18.07.17